Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReMed is a U.S. healthcare services company focused on post-acute brain injury rehabilitation and supported living rather than drug development. Founded in 1984 in Pennsylvania, the company built a regional franchise in acquired brain injury rehabilitation and later expanded through the combination with Learning Services Corp. to form Collage Rehabilitation Partners. Its services include residential neurorehabilitation, neurobehavioral rehabilitation, outpatient and day treatment, and home-and-community-based rehabilitation for individuals with complex neurological injuries. The ReMed brand continues to appear within the Collage network, especially in Pennsylvania, while the broader enterprise operates nationally under Collage Rehabilitation Partners. The business is commercial-stage and service-based, with no disclosed therapeutic pipeline in the biotech/pharma sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReMed Holdings.